Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LAB Hungary, currently operating as Charles River Laboratories Hungary, is a leading preclinical contract research organization (CRO) based in Veszprém, Hungary. The company provides a comprehensive range of safety assessment services, including general toxicology, safety pharmacology, and analytical chemistry, to the global pharmaceutical, biotechnology, and chemical industries. Originally established as Toxi-Coop and later becoming part of the LAB Research group, the facility was integrated into Citoxlab before its acquisition by Charles River Laboratories in 2019. The site is highly regarded for its GLP-compliant studies and specialized expertise in inhalation toxicology and environmental safety testing. As a key hub in Central Europe, it supports clients through the critical early stages of drug development and regulatory submission. The facility remains one of the largest and most established preclinical research centers in the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LAB Hungary.